Skip to main content
. 2021 Aug 19;13(8):1295. doi: 10.3390/pharmaceutics13081295

Figure 4.

Figure 4

Schematic representation of some Ru-based drug candidates. Different Ru-complexes mediated CRC cells apoptosis through DNA damage (1ad), inhibiting DNA topoisomerase II enzyme (2ac), and regulating MAPK signaling pathway (3ad).